Monitor for any subsequent conversion to a 13D or additional share accumulation, which would signal a shift from passive to activist intent. For now, the 10% stake is a passive vote of confidence from a small investment adviser post-IPO.
Price Chart
Executive Summary
B Group, Inc., B Group Capital LLC, and Branden B. Muhl filed a Schedule 13G disclosing passive beneficial ownership of 833,333 shares of Retension Pharmaceuticals common stock, representing 10.0% of shares outstanding post-IPO. This is a new 5%+ disclosure filed two days after the IPO closed, indicating a significant passive stake by an investment adviser and its control persons.
Key Financial Metrics
Key Facts
- B Group, Inc. and related entities hold 833,333 shares of Retension Pharmaceuticals common stock.
- The stake represents 10.0% of the 8,331,599 shares outstanding after the IPO (per the October 9, 2026 prospectus supplement).
- The filing is made under Rule 13d-1(c) — passive investment, no intent to influence control.
- The filing is dated October 16, 2026, two days after the IPO closed on October 13, 2026.
- The B Group, Inc. serves as investment adviser to B Group Capital LLC, which holds the shares directly.
- This is a new position (not an amendment) — the first 13G filing by these reporting persons for this issuer.
Financial Impact
10.0% passive stake valued at the IPO price (undisclosed in filing) — a meaningful but non-controlling position in a newly public company.
Risk Factors
- The 10% stake could trigger future filing obligations or lock-up considerations if the investor seeks to sell.
- As a passive filer, B Group has no stated intent to influence management, but large positions in small-cap biotechs can precede activist engagement.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0001213900-26-110378 |
| Document: 0001213900-26-110378-index-headers.html | 0001213900-26-110378 |
| Document: 0001213900-26-110378-index.html | 0001213900-26-110378 |
| Document: 0001213900-26-110378.txt | 0001213900-26-110378 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 3d ago | 8-K | $15.25 | awaiting T+5 | — | $14.24 (−6.62%) |
Oct 16, 2026 10d ago | SC 13G | $16.33 $14.65 | ▼ −10.29% | ▼ −10.14% | $14.24 (−12.80%) |
Oct 16, 2026 10d ago | SC 13G | $14.07 $15.25 | ▲ +8.39% | ▲ +8.82% | $14.24 (+1.21%) |
Oct 15, 2026 11d ago | SC 13G | $12.21 $15.50 | ▲ +26.95% | ▲ +27.96% | $14.24 (+16.63%) |
Oct 14, 2026 12d ago | SC 13D | $12.21 $15.50 | ▲ +26.95% | ▲ +27.96% | $14.24 (+16.63%) |
Oct 13, 2026 13d ago | Insider Cluster | $11.64 $15.00 | ▲ +28.87% | ▲ +28.41% | $14.24 (+22.34%) |
Oct 13, 2026 13d ago | 3 | $11.64 $15.00 | ▲ +28.87% | ▲ +28.41% | $14.24 (+22.34%) |
Oct 9, 2026 17d ago | 424B4 | $11.32 $16.33 | ▲ +44.26% | ▲ +45.75% | $14.24 (+25.80%) |
Oct 9, 2026 17d ago | EFFECT | $10.53 $14.07 | ▲ +33.62% | ▲ +35.59% | $14.24 (+35.23%) |
Oct 8, 2026 17d ago | 3 | $10.53 $14.07 | ▲ +33.62% | ▲ +35.59% | $14.24 (+35.23%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers